# MANA Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mana-therapeutics

- Industry: Biotechnology
- Headquarters: Arlington, US
- Website: www.manatherapeutics.com
- Total disclosed funding: $35M
- Latest round: Series A (Jan 8, 2021)
- Investors on record: 3

## About

MANA Therapeutics, Inc. specializes in developing innovative cell therapies aimed at treating various diseases, leveraging advanced biotechnology to improve patient outcomes.Founded in 2018 and headquartered in Arlington, US, MANA Therapeutics focuses on cell therapy innovations. The company has engaged in 3 deals, with its most recent funding round occurring on November 30, 2021. MANA Therapeutics raised USD 7.5 mn in VENTURE DEBT from Silicon Valley Bank, bringing its total capital raised to USD 35.0 mn. The company was established by C. Cruz and Patrick Hanley, and is currently led by CEO Mahmoud Mahmoudian.MANA Therapeutics develops next-generation cell therapies targeting various health conditions. Their current focus includes MANA-312 and MANA-412, which aim to enhance therapeutic effectiveness through innovative approaches in cell therapy, supporting both individual and clinical applications.The company generates revenue through strategic partnerships and funding rounds that support its research and development of cell therapies. MANA Therapeutics has raised a total of USD 35.0 mn, enabling the advancement of its therapeutic products and operational capabilities.Following its recent VENTURE DEBT round of USD 7.5 mn in November 2021, MANA Therapeutics plans to utilize this funding to accelerate the development of its upcoming cell therapies, MANA-312 and MANA-412. The company aims to expand its market presence and is targeting new therapeutic areas and geographic regions for its products, although specific markets and timelines have not been disclosed.

## Funding rounds

- Series A, Jan 8, 2021, $35M — Cobro Ventures, LifeSci Partners, Lightchain Capital
- Seed, Oct 18, 2018 — Cobro Ventures

## Investors

- Cobro Ventures (https://capitalatlas.ai/funds/cobro-ventures) — Seed, Series A
- LifeSci Partners (https://capitalatlas.ai/funds/lifesci-partners) — Series A
- Lightchain Capital (https://capitalatlas.ai/funds/lightchain-capital) — Series A